Topics

Orchard unveils positive data from beta thalassemia candidate's trial

06:09 EDT 1 May 2019 | SmartBrief

Orchard Therapeutics unveiled findings from its trial assessing the efficacy of its gene therapy candidate OTL-300 as a treat -More

Original Article: Orchard unveils positive data from beta thalassemia candidate's trial

NEXT ARTICLE

More From BioPortfolio on "Orchard unveils positive data from beta thalassemia candidate's trial"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...